The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
di er dai kang jing shen bing yao wu lin chuang ying yong ping jia
Author(s): 
Pages: 319-321
Year: Issue:  5
Journal: World Clinical Drugs

Abstract: 抗精神病药物主要分为第一代抗精神病药(FGA)和第二代抗精神病药(SGA).自1952年氯丙嗪问世至今,抗精神病药物已经历了半个世纪的发展.由于氯丙嗪的抗精神病作用与阻滞多巴胺D2受体有关,随之发展了一系列D2受体阻断剂的传统抗精神病药物,包括氟哌啶醇、奋乃静、舒必利、三氟拉嗪、氯普噻吨、五氟利多和硫利达嗪等,即FGA,又称典型抗精神病药.
Related Articles
No related articles found